TRPX

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TRPX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/27	05 : 05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/06/21	22 : 09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/06/16	22 : 09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/06/12	20 : 03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/05/31	05 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/05/17	19 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/05/17	06 : 31	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/05/08	21 : 24	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/05/06	05 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/04/21	22 : 13	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/04/05	19 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/04/04	20 : 08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/03/11	07 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/03/10	06 : 16	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/02/27	23 : 14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/02/27	21 : 47	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/02/17	20 : 01	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/02/17	07 : 25	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/02/15	22 : 35	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/01/26	06 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2023/01/10	06 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/12/15	06 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/12/08	03 : 09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/11/30	02 : 28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/11/17	06 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/11/08	21 : 34	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/11/02	05 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/09/30	20 : 28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/09/17	00 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd
2022/08/25	19 : 56	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:TRPX	Therapix Biosciences Ltd